IDENTIFICATION OF CANNABIMIMETIC MDMB(N)-073F METABOLITES IN URINE BY METHOD OF GAS CHROMATOGRAPHY WITH MASS SPECTROMETRIC DETECTION

Background. At the beginning of 2019, the use of a new representative of synthetic cannabimimetics of the methylbutanoate indazole carboxamides group, MDMB(N)-073F, was recorded in a number of regions in the Russian Federation. Characteristic features of the pharmacological effect, the clinical pict...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	S. S. Kataev, O. N. Dvorskaya, M. A. Gofenberg
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2019-05-01
Saila:	Фармация и фармакология (Пятигорск)
Gaiak:	mdmb(n)-073f cannabimimetics metabolism enzymatic hydrolysis solid-phase extraction (spe) gas chromatography – mass spectrometry
Sarrera elektronikoa:	https://www.pharmpharm.ru/jour/article/view/362
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!